Jane Street Group LLC Boosts Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Jane Street Group LLC raised its stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXSFree Report) by 26.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 29,773 shares of the company’s stock after buying an additional 6,313 shares during the quarter. Jane Street Group LLC’s holdings in Stereotaxis were worth $61,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. grew its holdings in Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after buying an additional 15,491 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of Stereotaxis during the 3rd quarter valued at about $39,000. State Street Corp boosted its position in shares of Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock valued at $1,388,000 after acquiring an additional 36,518 shares during the last quarter. Rhumbline Advisers boosted its position in shares of Stereotaxis by 645.6% during the 2nd quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock valued at $88,000 after acquiring an additional 41,780 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Stereotaxis by 247.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock valued at $345,000 after acquiring an additional 135,041 shares during the last quarter. Hedge funds and other institutional investors own 45.35% of the company’s stock.

Stereotaxis Stock Up 2.4 %

Shares of STXS opened at $2.12 on Thursday. The stock has a market cap of $179.63 million, a PE ratio of -7.57 and a beta of 1.57. Stereotaxis, Inc. has a 12-month low of $1.66 and a 12-month high of $3.29.

Stereotaxis (NYSEAMERICAN:STXSGet Free Report) last issued its quarterly earnings results on Monday, November 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). The business had revenue of $9.20 million for the quarter, compared to the consensus estimate of $6.80 million. Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. On average, equities analysts forecast that Stereotaxis, Inc. will post -0.26 earnings per share for the current year.

About Stereotaxis

(Free Report)

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

Featured Stories

Want to see what other hedge funds are holding STXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stereotaxis, Inc. (NYSEAMERICAN:STXSFree Report).

Institutional Ownership by Quarter for Stereotaxis (NYSEAMERICAN:STXS)

Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.